Biotech Breakthroughs: Drugs, AI, and Brain Health
Kilder
- STAT: Lilly’s ‘triple-G’ drug leads to bariatric-surgery levels of weight loss in trial - statnews.com
- Fierce Biotech: Lilly’s triple-G drug helps patients lose roughly a quarter of weight, showcasing competitive profile - Fierce Biotech
- BioPharma Dive: Lilly’s triple-acting obesity drug hits goal in Phase 3 trial - BioPharma Dive
- Bioworld: Another Triumph: Lilly’s triple G agonist scores in obesity - BioWorld News
- Fierce Biotech: Infex advances lung disease candidate after clearing phase 2a - Fierce Biotech
- Pharmaphorum: Infex chases after Insmed with bronchiectasis trial win - pharmaphorum
- BioPharma Dive: In Alzheimer’s, Bristol Myers sees big promise beyond amyloid - BioPharma Dive
- Bioworld: AI, remote care drive new models for Australian medtech - BioWorld News
- Bioworld: AI, remote care drive new models for Australian medtech - BioWorld News
- Newshub: AI-powered brain health project gets $30m boost - Medianet News Hub
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.